CD276 and neoplasm: Although a few cases of “likely” on-target off-tumor toxicities have emerged, these examples are surprisingly rare.8,56 The m276 anti-CD276 mAb used to make the CD276 ADC described here differs from those of most ADCs in that it was selected in vitro using a human antibody display library.